<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
--------------
Date of Report (Date of earliest event reported): September 15, 2000
Vertex Pharmaceuticals Incorporated
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Massachusetts 000-19319 04-3039129
----------------------- -------------------- -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
</TABLE>
130 WAVERLY STREET
CAMBRIDGE, MA 02139
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 577-6000
--------------------------------------------------------------------------------
Page 1 of 6 pages
<PAGE>
ITEM 5. OTHER EVENTS.
On September 15, 2000, we publicly disseminated a press release
announcing that we are calling our $175 million aggregate principal amount of
Convertible Subordinated Notes due March 2007 for redemption on October 5,
2000. The information contained in the press release is incorporated herein
by reference and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits.
99.1 Press Release dated September 15, 2000, "Vertex Pharmaceuticals
Calls for Redemption of Convertible Subordinated Notes due March
2007."
Page 2 of 6 pages
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VERTEX PHARMACEUTICALS INCORPORATED
(Registrant)
Date: September 15, 2000 By: /s/ Thomas G. Auchincloss, Jr.
---------------------------------
Name: Thomas G. Auchincloss, Jr.
Title: Vice President, Finance
Page 3 of 6 pages
<PAGE>
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number
------- ----------- -----------
99.1 Press Release dated September 5
15, 2000, "Vertex Pharmaceuticals
Calls for Redemption of Convertible
Subordinated Notes due March 2007."
Page 4 of 6 pages
